5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro

5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro

Abstract The coronavirus disease 2019 (COVID 19) pandemic continues to pose a threat to global health. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant (B.1.1.529) has spread rapidly worldwide and became dominant in many countries. A natural 5-aminolevulinic acid (5-A...

Full description

Bibliographic Details
Main Authors: Mya Myat Ngwe Tun, Takaya Sakura, Yasuteru Sakurai, Yohei Kurosaki, Daniel Ken Inaoka, Norifumi Shioda, Chris Smith, Jiro Yasuda, Kouichi Morita, Kiyoshi Kita
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Tropical Medicine and Health
Subjects:
SARS-CoV-2
Omicron variant
5-ALA
SFC
Antiviral activity
Online Access:https://doi.org/10.1186/s41182-022-00422-7

Internet

https://doi.org/10.1186/s41182-022-00422-7

Similar Items